推荐产品
生物源
rabbit
品質等級
重組細胞
expressed in HEK 293 cells
共軛
unconjugated
抗體表格
purified antibody
抗體產品種類
primary antibodies
無性繁殖
52H11, recombinant monoclonal
描述
52H11 Clone
產品線
ZooMAb® learn more
形狀
lyophilized
純化經由
using Protein A
物種活性
human
物種活性（以同源性預測）
all
包裝
antibody small pack of 25 μL
環保替代產品特色
Waste Prevention
Designing Safer Chemicals
Design for Energy Efficiency
Learn more about the Principles of Green Chemistry.
加強驗證
recombinant expression
Learn more about Antibody Enhanced Validation
sustainability
Greener Alternative Product
技術
ELISA: suitable
flow cytometry: suitable
immunocytochemistry: suitable
western blot: suitable
同型
IgG
UniProt登錄號
環保替代類別
, Aligned
運輸包裝
ambient
儲存溫度
2-8°C
目標翻譯後修改
carbamidomethylation (cam) (Cys)
一般說明
We are committed to bringing you greener alternative products, which adhere to one or more of The 12 Principles of Green Chemistry.This antibody is Preservative-free, produced without the harm or sacrifice of animals and exceptionally stable to allow for ambient shipping and storage if needed and thus aligns with "Waste Prevention", "Designing Safer Chemicals" and "Design for Energy Efficiency". Click here for more information.
ZooMAb® antibodies represent an entirely new generation of recombinant monoclonal antibodies.Each ZooMAb® antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Only top-performing clones are released for use by researchers. Each antibody is validated for high specificity and affinity across multiple applications, including its most commonly used application. ZooMAb® antibodies are reliably available and ready to ship when you need them.
特異性
Clone 52H11 is a ZooMAb® rabbit recombinant monoclonal antibody that detects Carbamidomethyl-cysteine (CAM-Cysteine) modified proteins.
免疫原
A liner peptide corresponding to 26 amino acids from the C-terminal region of human Myeloid associated differentiation marker like 2 ( MYADML2 ) with CAM modification at two Cysteine residues.
應用
Quality Control Testing
Evaluated by Western Blotting in lysate from HEK293 cells treated with Iodoacetamide.
Western Blotting Analysis (WB): A 1:1,000 dilution of this antibody detected CAM-cysteine modified proteins in lysate from HEK293 cells treated with Iodoacetamide (1 mM for 10 min), but not in untreated cells.
Tested applications
Immunocytochemistry Analysis: A 1:100 dilution from a representative lot detected CAM-cysteine modified proteins in HEK293 cells treated with Iodoacetamide (IAM).
Enzyme Immunoassay Analysis (ELISA): A serial of dilution from a representative lot detected CAM-cysteine modified proteins in HEK293 cells treated with Iodoacetamide (IAM).
Flow Cytometry Analysis: 0.1 μg from a representative lot detected CAM-cysteine modified proteins in HEK293 cells treated with Iodoacetamide (IAM).
Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user
Evaluated by Western Blotting in lysate from HEK293 cells treated with Iodoacetamide.
Western Blotting Analysis (WB): A 1:1,000 dilution of this antibody detected CAM-cysteine modified proteins in lysate from HEK293 cells treated with Iodoacetamide (1 mM for 10 min), but not in untreated cells.
Evaluated by Western Blotting in lysate from HEK293 cells treated with Iodoacetamide.
Western Blotting Analysis (WB): A 1:1,000 dilution of this antibody detected CAM-cysteine modified proteins in lysate from HEK293 cells treated with Iodoacetamide (1 mM for 10 min), but not in untreated cells.
Tested applications
Immunocytochemistry Analysis: A 1:100 dilution from a representative lot detected CAM-cysteine modified proteins in HEK293 cells treated with Iodoacetamide (IAM).
Enzyme Immunoassay Analysis (ELISA): A serial of dilution from a representative lot detected CAM-cysteine modified proteins in HEK293 cells treated with Iodoacetamide (IAM).
Flow Cytometry Analysis: 0.1 μg from a representative lot detected CAM-cysteine modified proteins in HEK293 cells treated with Iodoacetamide (IAM).
Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user
Evaluated by Western Blotting in lysate from HEK293 cells treated with Iodoacetamide.
Western Blotting Analysis (WB): A 1:1,000 dilution of this antibody detected CAM-cysteine modified proteins in lysate from HEK293 cells treated with Iodoacetamide (1 mM for 10 min), but not in untreated cells.
標靶描述
Post-translation regulation of cysteine sulfhydryl groups can affect molecular function of proteins. In several secreted proteins, cysteine thiols undergo oxidation to form intramolecular disulfide bonds, which play key roles in protein secondary structure and function. In order to be quantified in a protein cysteine residue requires modification. Thiol group of cysteine can be blocked by a variety of reagents, including iodoacetic acid and iodoacetamide. Iodoacetate treatment can produce S-carboxymethyl derivative of cysteine, but it introduces a new negative charge into protein. However, when such charge difference is undesirable, iodoacetamide is used to derivatize cysteine to produce carboxamidomethyl cysteine, an irreversible covalent product. These modifications in proteins can serve as markers for cysteine-AGE formation and can be used as marker for mitochondrial damage during aging. Antibodies that react with carbamidomethyl-cysteine (CAM-cys) can provide multiple protein bands when subjected to Western blotting of lysates treated with iodoacetamide. This ZooMAbZooMAb® recombinant monoclonal antibody, generated by our propriety technology, offers significantly enhanced specificity, affinity, reproducibility, and stability over conventional monoclonals. (Ref.: Cartee, NMP., and Wang, MM. (2020). PLoS ONE 15(9); e0239464; Cartee, NMP., et al. (2020). PLoS One. 15(11); e0242376).
外觀
Purified recombinant rabbit monoclonal antibody IgG, lyophilized in PBS, 5% Trehalose, normal appearance a coarse or translucent resin. The PBS/trehalose components in the ZooMAb formulation can have the appearance of a semi-solid (bead like gel) after lyophilization. This is a normal phenomenon. Please follow the recommended reconstitution procedure in the data sheet to dissolve the semi-solid, bead-like, gel-appearing material. The resulting antibody solution is completely stable and functional as proven by full functional testing. Contains no biocide or preservatives, such as azide, or any animal by-products. Larger pack sizes provided as multiples of 25 μL.
重構
300 μg/mL after reconstitution at 25 μL per vial. Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.
儲存和穩定性
Recommend storage of lyophilized product at 2-8°C; Before reconstitution, micro-centrifuge vials briefly to spin down material to bottom of the vial; Reconstitute each vial by adding 25 μL of filtered lab grade water or PBS; Reconstituted antibodies can be stored at 2-8°C, or -20°C for long term storage. Avoid repeated freeze-thaws.
法律資訊
ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany
免責聲明
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
未找到合适的产品？
试试我们的产品选型工具.
儲存類別代碼
11 - Combustible Solids
水污染物質分類（WGK）
WGK 1
閃點（°F）
Not applicable
閃點（°C）
Not applicable
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门